PLoS ONE · 2013 · 48 citations · 20 references
MedicineCardiologyPharmacologyApoptosisDrug DeliveryMolecular PharmacologyAntioxidant DefenseApoptosis PharmacologyCardiac BiomarkersCardiac PharmacotherapyHeart Failure PharmacotherapyReactive Oxygen SpeciesCardiac Systolic FunctionCardioprotective TherapyCysteine OxidationHeart Failure PharmacologyHydrogen Sulfide OxidationHydrogen Sulfide ReleaseInfarct Size QuantificationMechanisms Of Cardiac Injury
OBJECTIVE: Heart failure (HF) is one of the most serious diseases worldwide. S-propargyl-cysteine (SPRC), a novel modulator of endogenous hydrogen sulfide, is proved to be able to protect against acute myocardial ischemia. In order to produce more stable and sustainable hydrogen sulfide, we used controlled release formulation of SPRC (CR-SPRC) to elucidate possible cardioprotective effects on HF rats and investigate involved mechanisms on apoptosis and oxidation. METHODS: Left coronary artery was occluded to induce HF model of rat. The survival rats were randomly divided into 7 groups after 24 hours and treated with drugs for 6 weeks. Echocardiographic indexes were recorded to determine cardiac function. TTC staining was performed to determine infarct size. Plasmatic level of hydrogen sulfide was detected by modified sulfide electrode. Activity of enzyme and expression of protein were determined by colorimetry and Western blot, respectively. RESULTS: The cardioprotective effects of CR-SPRC on HF rats were confirmed by significant reduction of infarct size and improvement of cardiac function, with better effects compared to normal SPRC. CR-SPRC modulated antioxidant defenses by preserving levels of GSH, CAT and SOD and reducing CK leakage. In addition, CR-SPRC elevated ratio of Bcl-2/Bax and inhibited activity of caspases to protect against myocardial apoptosis. The cardioprotective effects of CR-SPRC were mediated by hydrogen sulfide. CONCLUSIONS: All experiment data indicated cardioprotective effects of CR-SPRC on HF rats. More importantly, CR-SPRC exerted better effects than normal SPRC in all respects, providing a new perspective on hydrogen sulfide-mediated drug therapy.
20
Guangdong Yang, Lingyun Wu, Bo Jiang et al. · Science · 2008 · 2.3K citations · Full text
The possible role of hydrogen sulfide as an endogenous neuromodulator
K. Abe, Hideo Kimura · Journal of Neuroscience · 1996 · 2.2K citations · Full text
The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener
Weimin Zhao, Jing Zhang, Yanjie Lu et al. · The EMBO Journal · 2001 · 1.9K citations · Full text
Apoptosis in Myocytes in End-Stage Heart Failure
Jagat Narula, Nezam Haider, Renu Virmani et al. · New England Journal of Medicine · 1996 · 1.4K citations · Full text
Medicine, Cardiology, Pathology +11